Denise Bonamici
Director, Regulatory Affairs Brazil and LATAM at Vertex Pharmaceuticals | São Paulo, São Paulo, Brazil
Denise Bonamici’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Director, Regulatory Affairs Brazil and LATAM at Vertex Pharmaceuticals in July 2019 - Present
Head of Regulatory Science & Policy - LATAM at Sanofi in October 2016 - July 2019
Director, Regulatory Affairs LATAM, OTC at Teva Pharmaceuticals in January 2014 - September 2016
Regulatory Affairs Manager at Pfizer Consumer Healthcare in February 2011 - January 2014
Regulatory Affairs Manager at Ferring Pharmaceuticals in March 2010 - February 2011
Regulatory Affairs Manager at Johnson & Johnson in September 2007 - March 2010
Regulatory Affairs Coordinator at Roche in December 1999 - August 2007
Marketing Associate at Novartis Pharma in December 1994 - August 1999
Regulatory Affairs Associate at Zeneca in January 1993 - January 1994
Universidade de São Paulo, Master’s Degree
SLAC coachimg, Executive Coaching certification
Fundacao Getulio Vargas / FGV, Master of Business Administration (MBA)
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
Discover more about Vertex Pharmaceuticals
General Manager | Business Development | Operations and Distribution | Go-To-Market Strategies | Turnaround & Crisis Management | FMCG, Medical Device & Pharma Experience
Commercial Director CEE and Turkey at Vertex Pharmaceuticals
(July 2022 – Present)
Senior Key Account Manager
Senior Key Account Manager at Vertex Pharmaceuticals
(August 2022 – Present)
Senior Research Scientist - Spatial Multi Omics, Immunology
Senior Research Scientist - Spatial Multi Omics, Immunology at Vertex Pharmaceuticals
(August 2023 – Present)
Compliance and Operations professional
GMP Operational Quality Senior Specialist at Vertex Pharmaceuticals
(May 2023 – Present)
Global Head Computational Drug Design at Vertex Pharmaceuticals
Global Head, Computational Drug Design at Vertex Pharmaceuticals
(August 2021 – Present)
Seasoned Communications & Engagement professional
Vice-chair & Treasurer at EUPATI Belgium
(May 2022 – Present)
What is Denise Bonamici email address?
Email Denise Bonamici at [email protected] and [email protected]. This email is the most updated Denise Bonamici's email found in 2026.
How to contact Denise Bonamici?
To contact Denise Bonamici send an email to [email protected] or [email protected].
What company does Denise Bonamici work for?
Denise Bonamici works for Vertex Pharmaceuticals.
What is Denise Bonamici's role at Vertex Pharmaceuticals?
Denise Bonamici is Director, Regulatory Affairs Brazil and LATAM
What industry does Denise Bonamici work in?
Denise Bonamici works in the Biotechnology industry.
